Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management

References

• Samitas K, Zervas E, Gaga M. T2-low asthma: current approach to diagnosis and therapy. Curr Opin Pulm Med 2017;23(1):48–55. doi:10.1097/MCP.0000000000000342.
   PubMed Web of Science ®Google Scholar
• Thomson NC. Novel approaches to the management of noneosinophilic asthma. Ther Adv Respir Dis 2016;10(3):211–234. doi:10.1177/1753465816632638.
   PubMed Web of Science ®Google Scholar
• Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med 2018;197(1):22–37. doi:10.1164/rccm.201611-2232PP.
   PubMed Web of Science ®Google Scholar
• Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, Lin S-L. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 2013;188(11):1294–1302. doi:10.1164/rccm.201212-2318OC.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353(9171):2213–2214. doi:10.1016/S0140-6736(99)01813-9.
   PubMed Web of Science ®Google Scholar
• Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, Bradding P, Wardlaw AJ, Pavord ID. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007;62(12):1043–1049. doi:10.1136/thx.2006.073429.
   PubMed Web of Science ®Google Scholar
• Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57(10):875–879. doi:10.1136/thorax.57.10.875.
   PubMed Web of Science ®Google Scholar
• Bacci E, Cianchetti S, Bartoli ML, Dente FL, Di Franco A, Vagaggini B, Paggiaro P. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 2006;129(3):565–572. doi:10.1378/chest.129.3.565.
   PubMed Web of Science ®Google Scholar
• Demarche SF, Schleich FN, Henket MA, Paulus VA, Van Hees TJ, Louis RE. Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre. BMJ Open 2017;7(11):e018186. doi:10.1136/bmjopen-2017-018186.
   PubMed Web of Science ®Google Scholar
• Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65(5):384–390. doi:10.1136/thx.2009.126722.
   PubMed Web of Science ®Google Scholar
• Godon P, Boulet LP, Malo JL, Cartier A, Lemière C. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J 2002;20(6):1364–1369. doi:10.1183/09031936.02.00017502.
   PubMed Web of Science ®Google Scholar
• Lemière C, Tremblay C, FitzGerald M, Aaron SD, Leigh R, Boulet LP, Martin JG, Nair P, Olivenstein R, Chaboillez S. Effects of a short course of inhaled corticosteroids in noneosinophilic asthmatic subjects. Can Respir J 2011;18(5):278–282. doi:10.1155/2011/108079.
   PubMed Web of Science ®Google Scholar
• Demarche S, Schleich F, Henket M, Paulus V, Louis R, Van Hees T. Step-down of inhaled corticosteroids in non-eosinophilic asthma: a prospective trial in real life. Clin Exp Allergy 2018;48(5):525–535. doi:10.1111/cea.13106.
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, Lugogo N, Wenzel S, Chinchilli VM, Mauger DT, et al. Mometasone or tiotropium in mild asthma with a low sputum eosinophil level. N Engl J Med 2019;380(21):2009–2019. doi:10.1056/NEJMoa1814917.
   PubMed Web of Science ®Google Scholar
• Chapman DG, Irvin CG. Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come. Clin Exp Allergy 2015;45(4):706–719. doi:10.1111/cea.12506.
   PubMed Web of Science ®Google Scholar
• Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet L-P, O'Byrne PM. Airway hyperresponsiveness in asthma: measurement and clinical relevance. J Allergy Clin Immunol Pract 2017;5(3):649–659.e2. doi:10.1016/j.jaip.2016.11.030.
   PubMed Web of Science ®Google Scholar
• Anderson SD. 'Indirect' challenges from science to clinical practice. Eur Clin Respir J 2016 ;3(1):31096. doi:10.3402/ecrj.v3.31096.
   PubMed Web of Science ®Google Scholar
• Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. Allergy Eur J Allergy Clin Immunol 2006;61(12):1473–1479. doi:10.1111/j.1398-9995.2006.01213.x.
   Google Scholar
• Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003;22(3):491–496. doi:10.1183/09031936.03.00113403.
   PubMed Web of Science ®Google Scholar
• Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006;27(5):944–950. doi:10.1183/09031936.06.00078205.
   PubMed Web of Science ®Google Scholar
• Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol 2012;3:460. doi:10.3389/fphys.2012.00460.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Jeffery PK, Qiu Y, Zhu J, Parker D, Carlsheimer Å, Naya I, Barnes NC. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol 2009;123(5):1083–1089.e7. doi:10.1016/j.jaci.2009.02.034.
   PubMed Web of Science ®Google Scholar
• James A, Gyllfors P, Henriksson E, Dahlén SE, Adner M, Nilsson G, Dahlén B. Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi. Allergy Eur J Allergy Clin Immunol 2012;67(7):958–961. doi:10.1111/j.1398-9995.2012.02836.x.
   Google Scholar
• Backer V, Sverrild A, Ulrik CS, Bødtger U, Seersholm N, Porsbjerg C. Diagnostic work-up in patients with possible asthma referred to a university hospital. Eur Clin Respir J 2015;2(1):27768. doi:10.3402/ecrj.v2.27768.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, ATS/ERS Task Force Standardisation of Spirometry. Eur Respir J 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Brannan J, Spring J, Spalding N, Rodwell Leanne T, Chan K, Gonda I, Walsh A, Clark AR. A new method for bronchial–provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997;156(3):758–765. doi:10.1164/ajrccm.156.3.9701113.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161(1):309–329. doi:10.1164/ajrccm.161.1.ats11-99.
   PubMed Web of Science ®Google Scholar
• Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ, Sterk PJ. Sputum induction. Eur Respir J Suppl 2002;37(37 suppl):3s–8s. doi:10.1183/09031936.02.00000302.
   PubMedGoogle Scholar
• Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MMM, Pizzichini E, Ronchi C, Van Overvel F, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002;37(37 suppl):19s–23s. doi:10.1183/09031936.02.00001902.
   PubMedGoogle Scholar
• Heinzerling L, Mari A, Bergmann K-C, Bresciani M, Burbach G, Darsow U, Durham S, Fokkens W, Gjomarkaj M, Haahtela T, et al. The skin prick test – European standards. Clin Transl Allergy 2013;3(1):3. doi:10.1186/2045-7022-3-3.
   PubMedGoogle Scholar
• Silkoff PE, Laviolette M, Singh D, FitzGerald J, Mark Kelsen S, Backer V, Porsbjerg CM, Girodet PO, Berger P, Kline JN, Chupp G, Susulic VS, Barnathan ES, Baribaud F, Loza MJ, Strambu I, Lam S, Eich A, Ludwig-Sengpiel A, Airways Disease Endotyping for Personalized Therapeutics (ADEPT) Study Investigators. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients. J Allergy Clin Immunol 2017;140(3):710–719. doi:10.1016/j.jaci.2016.11.038.
   PubMed Web of Science ®Google Scholar
• Peat JK, Unger WR, Combe D. Measuring changes in logarithmic data, with special reference to bronchial responsiveness. J Clin Epidemiol 1994;47(10):1099–1108. doi:10.1016/0895-4356(94)90096-5.
   PubMed Web of Science ®Google Scholar
• Brannan John D, Koskela H, Anderson SD, Chan HK. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002;7(1):37–44. doi:10.1046/j.1440-1843.2002.00357.x.
   PubMed Web of Science ®Google Scholar
• Du Toit JI, Anderson SD, Jenkins CR, Woolcock AJ, Rodwell LT. Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide. Allergy Asthma Proc 1997;18(1):7–14. doi:10.2500/108854197778612817.
   PubMed Web of Science ®Google Scholar
• Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax 1991;46(11):811–816. doi:10.1136/thx.46.11.811.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346(22):1699–1705. doi:10.1056/NEJMoa012705.
   PubMed Web of Science ®Google Scholar
• Patel JK, Clifford RL, Deacon K, Knox AJ. Ciclesonide inhibits TNFα- and IL-1β-induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2012;302(8):L785–L792. doi:10.1152/ajplung.00257.2011.
   PubMed Web of Science ®Google Scholar
• Kang BN, Jude JA, Panettieri RA, Walseth TF, Kannan MS. Glucocorticoid regulation of CD38 expression in human airway smooth muscle cells: role of dual specificity phosphatase 1. Am J Physiol Lung Cell Mol Physiol 2008;295(1):L186–L193. doi:10.1152/ajplung.00352.2007.
   PubMed Web of Science ®Google Scholar
• Goldsmith AM, Hershenson MB, Wolbert MP, Bentley JK. Regulation of airway smooth muscle α-actin expression by glucocorticoids. Am J Physiol Lung Cell Mol Physiol 2007;292(1):L99–L106. doi:10.1152/ajplung.00269.2006.
   PubMed Web of Science ®Google Scholar
• Xie S, Sukkar MB, Issa R, Khorasani NM, Chung KF. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-β. Am J Physiol Lung Cell Mol Physiol 2007;293(1):L245–L253. doi:10.1152/ajplung.00068.2007.
   PubMed Web of Science ®Google Scholar
• Yick CY, Zwinderman AH, Kunst PW, Grünberg K, Mauad T, Fluiter K, Bel EH, Lutter R, Baas F, Sterk PJ. Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthma. Am J Respir Crit Care Med. 2013;187(10):1076–1084. doi:10.1164/rccm.201210-1886OC.
   PubMed Web of Science ®Google Scholar
• Lim SAM, Jatakanon A, John M, Gilbey T, O'Connor B J, Chung KF, Barnes PJ. Effect of inhaled budesonide on lung function and airway inflammation assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999;159(1):22–30. doi:10.1164/ajrccm.159.1.9706006.
   PubMed Web of Science ®Google Scholar